Skip to main content

On Stage and in Song

As part of his 2012 TedMed talk, the US National Institutes of Health Director Francis Collins says that the time between understanding the molecular cause of a disease and developing a drug to treat that disease is too long, and the process is too expensive. Collins further suggests that drugs that have been shown to be safe in humans — though not effective for their original target diseases — could be repurposed for other diseases, as the new National Center for Advancing Translational Sciences is aiming to do.

Collins also joined singer Jill Sobule on the stage.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.